Transmedics Group, Inc. Comparables

Find the most relevant public market comparables for Transmedics Group, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.

Company Overview

TransMedics Group, Inc. is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. They developed the Organ Care System (OCS) to replace a decades-old standard of care, aiming to significantly increase access to life-saving transplant therapy. The OCS replicates many aspects of an organ's natural living and functioning environment outside the human body.

Business Model

Development and commercialization of the Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that preserves and delivers human organs for transplant in a near-physiologic condition.

Target Customers

Hospitals and transplant centers performing heart, lung, and liver transplants.

Specific Focus

Portable extracorporeal warm perfusion and assessment of donor organs for transplantation.

Location

Andover, Massachusetts

CEO

Dr. Waleed Hassanein

Industry

Life sciences

Sub Sector

Organ Preservation and Transplantation

3yr Revenue Growth

842%

Public Market Comparables

Below are the key valuation metrics for companies similar to Transmedics Group, Inc. in the Medical Technology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.

Looking for a comprehensive compset for Transmedics Group, Inc.? Our platform provides detailed analysis of Transmedics Group, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Transmedics Group, Inc. compset by trying our platform today.

EV/Revenue Multiple

Min

0.0x

Median

0.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details

EV/EBITDA Multiple

Min

00.0x

Median

00.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details
Screenshot of CompSetFinder showing Transmedics Group, Inc. comps with valuation metrics like EV/Revenue, EV/EBITDA, and P/E

Unlock the Full Transmedics Group, Inc. Compset

As a leading player in the Life sciences industry within the Medical Technology sector, Transmedics Group, Inc. operates in the specialized Organ Preservation and Transplantation sub-sector. Understanding how Transmedics Group, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.

Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Organ Preservation and Transplantation space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.

Get Your Custom Comparable Analysis

Need a more detailed analysis of Transmedics Group, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.

Try CompsetFinder Free